
TriSalus Life Sciences, Inc. – NASDAQ:TLSI
TriSalus Life Sciences stock price today
TriSalus Life Sciences stock price monthly change
TriSalus Life Sciences stock price quarterly change
TriSalus Life Sciences stock price yearly change
TriSalus Life Sciences key metrics
Market Cap | 124.10M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -6.17 |
Revenue | 21.98M |
EBITDA | -55.35M |
Income | -63.98M |
Revenue Q/Q | 116.38% |
Revenue Y/Y | 68.95% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -251.79% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTriSalus Life Sciences stock price history
TriSalus Life Sciences stock forecast
TriSalus Life Sciences financial statements
$10.5
Potential upside: 125.80%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 4.61M | -13.97M | -302.99% |
---|---|---|---|
Sep 2023 | 5.19M | -1.28M | -24.76% |
Dec 2023 | 5.72M | -35.50M | -620.68% |
Mar 2024 | 6.45M | -13.21M | -204.72% |
2024-04-01 | -0.69 | -1.56 |
---|---|---|
2024-05-15 | -0.65 | -0.54 |
Jun 2023 | 16811000 | 215.17M | 1279.96% |
---|---|---|---|
Sep 2023 | 33554000 | 25.06M | 74.71% |
Dec 2023 | 25725000 | 51.66M | 200.83% |
Mar 2024 | 17889000 | 52.81M | 295.22% |
Jun 2023 | -9.22M | -30K | 6.40M |
---|---|---|---|
Sep 2023 | -21.45M | -1.31M | 40.25M |
Dec 2023 | -8.84M | -700K | 43K |
Mar 2024 | -10.86M | -66K | 3.12M |
TriSalus Life Sciences alternative data
Dec 2023 | 106 |
---|---|
Jan 2024 | 106 |
Feb 2024 | 106 |
Mar 2024 | 106 |
Apr 2024 | 106 |
May 2024 | 112 |
Jun 2024 | 112 |
Jul 2024 | 101 |
TriSalus Life Sciences other data
Period | Buy | Sel |
---|---|---|
Aug 2024 | 0 | 9 |
Sep 2024 | 19815 | 0 |
Nov 2024 | 15727 | 0 |
Dec 2024 | 62972 | 30000 |
Quarter | Transcript |
---|---|
Q1 2024 15 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 1 Apr 2024 | Q4 2023 Earnings Call Transcript |
-
What's the price of TriSalus Life Sciences stock today?
One share of TriSalus Life Sciences stock can currently be purchased for approximately $4.65.
-
When is TriSalus Life Sciences's next earnings date?
Unfortunately, TriSalus Life Sciences's (TLSI) next earnings date is currently unknown.
-
Does TriSalus Life Sciences pay dividends?
No, TriSalus Life Sciences does not pay dividends.
-
How much money does TriSalus Life Sciences make?
TriSalus Life Sciences has a market capitalization of 124.10M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49.31% to 18.51M US dollars. TriSalus Life Sciences made a loss 59.04M US dollars in net income (profit) last year or -$0.54 on an earnings per share basis.
-
What is TriSalus Life Sciences's stock symbol?
TriSalus Life Sciences, Inc. is traded on the NASDAQ under the ticker symbol "TLSI".
-
What is TriSalus Life Sciences's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of TriSalus Life Sciences?
Shares of TriSalus Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does TriSalus Life Sciences have?
As Jul 2024, TriSalus Life Sciences employs 101 workers, which is 10% less then previous month and 5% less then previous quarter.
-
When TriSalus Life Sciences went public?
TriSalus Life Sciences, Inc. is publicly traded company for more then 4 years since IPO on 8 Feb 2021.
-
What is TriSalus Life Sciences's official website?
The official website for TriSalus Life Sciences is trisaluslifesci.com.
-
Where are TriSalus Life Sciences's headquarters?
TriSalus Life Sciences is headquartered at 6272 West 91st Avenue, Westminster, CO.
-
How can i contact TriSalus Life Sciences?
TriSalus Life Sciences's mailing address is 6272 West 91st Avenue, Westminster, CO and company can be reached via phone at +888 3215212.
-
What is TriSalus Life Sciences stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for TriSalus Life Sciences in the last 12 months, the avarage price target is $10.5. The average price target represents a 125.80% change from the last price of $4.65.
TriSalus Life Sciences company profile:

TriSalus Life Sciences, Inc.
trisaluslifesci.comNASDAQ
107
Medical - Devices
Healthcare
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
Westminster, CO 80031
CIK: 0001826667
ISIN: US89680M1018
CUSIP: 89680M101